Retatrutide administered once weekly subcutaneously for 12 weeks resulted in a dose-dependent placebo-adjusted weight loss of up to 8.96 kg in the highest dose group and a placebo-adjusted HbA1c reduction of up to 1.6% in a phase II trial in individuals with T2DM [125]
Weight loss was 6.0% (6.4 kg), 4.7% (5.0 kg), and 2.0% (2.2 kg) with liraglutide 3.0 mg, liraglutide 1.8 mg, and placebo, respectively
BPC-157 was prohibited under WADA's S0 Unapproved Substances category in 2022, restricting use in competition and training
Enjoy it as a pre-meal boost, or add it to your favorite smoothie or shake for a seamless and satisfying fiber addition
Seiwerth S et al
As much as Krupa Koestline, the cosmetic chemist we interviewed for this guide, likes vitamin C formulations, she still considers vitamin C to be among the most overrated skin-care ingredients